Quantitative determination of mitomycin C in biological materials by high-performance liquid chromatography and pharmacokinetics of mitomycin C in cancer patients.

Hakutaka Hashizume(Higashi Nagoya National Hospital), Yo Horiuchi(Higashi Nagoya National Hospital), EIZO SAJI, Keiji Yasue(Higashi Nagoya National Hospital), S Suga(Higashi Nagoya National Hospital), Kenji Ina, Yoshiko Usami(University of Massachusetts Chan Medical School)
Medical Entomology and Zoology
January 1, 1988
Cited by 0

Related Papers

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
|Nature|2015|466
Structural Basis for Budding by the ESCRT-III Factor CHMP3
|Developmental Cell|2006|254
Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface
|Biochemical Journal|1993|213
Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding
|Proceedings of the National Academy of Sciences|2006|182
Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin Ectodomain
|Cell Host & Microbe|2010|152